Background illustration for clinical trials search

Ophthalmology Clinical Trials

Browse 807 Ophthalmology clinical trials enrolling across the United States and Canada. 92 people applied to Ophthalmology studies last month. Search by city or state to find one near you.

Filter
1
Active & Responsive

tDCS as Treatment for Motor Function

for
Progressive Supranuclear Palsy,
Location: Toronto
Sponsor: Baycrest

Sex: All

Age: 0+

Code: NCT07291687

Recruiting
Active & Responsive

PAVE (Parallactic Visual-Field Enhancement) System for Treatment of Chronic Visual Field Loss Due to Stroke, Traumatic Brain Injury, or Brain Surgery

for
Homonymous Hemianopsia, Homonymous Quadrantanopia
Location: Cedar Rapids IA, Prospect KY
Sponsor: NeuroAEye LLC

Sex: All

Age: 21 - 70+

Code: NCT07185971

Recruiting
Active & Responsive

Evaluating a New Therapy for Dry Eye in Patients With Sjögren's Syndrome

for
Sjogren Syndrome With Keratoconjunctivitis
Location: Venice FL
Sponsor: Center For Sight

Sex: All

Age: 18+

Code: NCT07277257

Recruiting
Active & Responsive

Evaluating Injection With the Use of Brimonidine Tartrate Ophthalmic 0.025% on Patients Using Netarsudil 0.02%/Latanoprost 0.005% to Treat Glaucoma

for
Glaucoma
Location: Kansas City MO
Sponsor: Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,

Sex: All

Age: 18 - 65

Code: NCT07209410

Recruiting
Active & Responsive

Adaptive Optics OCT Evaluation of Rhopressa's Effects on the Retinal Ganglion Cells in Glaucoma Patients

for
Open Angle Glaucoma (OAG), Glaucoma
Location: Bloomington IN
Sponsor: Brett King

Sex: All

Age: 18+

Code: NCT07847073

Phase 4, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

DaxibotulinumtoxinA for Blepharospasm

for
Blepharospasm of Both Eyelids, Blepharospasm of Left Eyelid,
Location: Philadelphia PA
Sponsor: University of Pennsylvania

Sex: All

Age: 18+

Code: NCT07489430

Phase 2, Recruiting
Active & Responsive

Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma

for
Metastatic Uveal Melanoma, Uveal Melanoma, Metastatic,
Location: Nashville TN, Denver CO, Scottsdale AZ
Sponsor: Novelwise Pharmaceutical Corporation

Sex: All

Age: 18+

Code: NCT07136181

Phase 1, Phase 2, Recruiting
Active & Responsive

Study of Adjuvant Darovasertib and Crizotinib in Participants With Primary Non-metastatic Uveal Melanoma

for
Uveal Melanoma
Location: Philadelphia PA, Toronto, Nashville TN, Scottsdale AZ
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07804186

Phase 3, Recruiting
Active & Responsive

A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)

for
Diabetic Retinopathy, Macular Edema
Location: Manchester CT, Bloomfield NJ, Cherry Hill NJ, Towson MD,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07705555

Phase 3, Recruiting
Active & Responsive

A Study to Assess Brillouin Hydration Mapping for the Evaluation of Ocular Tissues and Diseases

for
Fuchs Endothelial Corneal Dysfunction,
Location: Boston MA
Sponsor: Massachusetts General Hospital

Sex: All

Age: 20 - 70+

Code: NCT07780890

Recruiting
Active & Responsive

A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.

for
Graves Disease
Location: Montreal, Surrey
Sponsor: argenx

Sex: All

Age: 18+

Code: NCT07596849

Phase 3, Recruiting
Active & Responsive

A Study to Evaluate the Efficacy and Safety of Tabirafusp Tedromer Compared to Aflibercept in Participants With DME - ALTO

for
Diabetic Macular Edema (DME)
Location: Waterford CT, Hauppauge NY, Hagerstown MD,
Sponsor: Kodiak Sciences Inc

Sex: All

Age: 18+

Code: NCT07734844

Phase 3, Recruiting
Active & Responsive

Phase 3 Study to Assess Efficacy, Safety & Tolerability of OCU410 For Geographic Atrophy Secondary to Dry AMD

for
Dry Age-related Macular Degeneration
Location: McAllen TX
Sponsor: Ocugen

Sex: All

Age: 55+

Code: NCT07770828

Phase 3, Recruiting
Active & Responsive

Valproate for the Treatment of Residual Amblyopia

for
Amblyopia, Amblyopia Unilateral, Amblyopia, Anisometropic,
Location: Boston MA
Sponsor: Boston Children's Hospital

Sex: All

Age: 8 - 17

Code: NCT07226141

Phase 1, Phase 2, Recruiting
Active & Responsive

Telehealth Music Therapy for Adults With Endocrine Disorder and Depression

for
Type 1 Diabetes, Hashimoto Disease, Graves Disease,
Location: Boone NC
Sponsor: Appalachian State University

Sex: All

Age: 18 - 65

Code: NCT07413874

Recruiting
Active & Responsive

Clinical Evaluation of WaveLight Plus LASIK

for
Myopia, Astigmatism
Location: Greensboro NC
Sponsor: Laser Defined Vision

Sex: All

Age: 18+

Code: NCT07127757

Recruiting
Active & Responsive

Evaluation of YB-101 for Safety, Tolerability, Pharmacokinetics, and Efficacy in Graves' Disease

for
Graves' Disease
Location: Sayre PA, Cary NC, Miami Lakes FL, Orchard Park NY,
Sponsor: Yarrow Bioscience, Inc.

Sex: All

Age: 18+

Code: NCT07682896

Phase 2, Recruiting
Active & Responsive

Effect of Lutein, Zeaxanthin, and Meso-Zeaxanthin Supplementation on Skin Carotenoid Concentration: A Six-Month, Placebo-Controlled Crossover Study

for
Macular Degenerative Disease
Location: Kansas City MO
Sponsor: Insight Eyecare Specialties, Inc. dba Vision Source Eyecare,

Sex: All

Age: 18+

Code: NCT06965426

Recruiting
Active & Responsive

A Study to Evaluate Efficacy and Safety of YSBP Compared to Lumigan in Patients With Glaucoma or Ocular Hypertension

for
Primary Open Angle Glaucoma (POAG), Ocular Hypertension (OH)
Location: Newport Beach CA
Sponsor: YS Life Science Co., Ltd.

Sex: All

Age: 18+

Code: NCT07661329

Phase 3, Recruiting
Active & Responsive

Vision Rehabilitation Training With Multimodal Feedback in Central Vision Loss

for
Low Vision, Central Visual Impairment, Macular Degeneration
Location: Boston MA
Sponsor: New England College of Optometry

Sex: All

Age: 14+

Code: NCT07577219

Recruiting

What are ophthalmology clinical trials?

Ophthalmology clinical trials are research studies designed to evaluate new treatments, therapies, or diagnostic methods for eye diseases and conditions. These trials focus on a wide range of ophthalmic issues, including but not limited to glaucoma, age-related macular degeneration (AMD), diabetic retinopathy, cataracts, and retinal diseases. Clinical trials in ophthalmology may test new medications, surgical techniques, laser treatments, or medical devices to improve vision, prevent blindness, or manage symptoms of eye diseases.

The data collected from these trials helps advance understanding and development of better treatment options, ultimately aiming to enhance eye health and visual outcomes for patients.

Why are clinical trials for ophthalmology important?

With a vast range of eye conditions and diseases falling under the ophthalmology umbrella, clinical research in this area is highly important. Ophthalmology clinical trials are crucial for driving the development of new and more effective treatments for eye diseases and conditions, which can significantly impact vision and quality of life.

Clinical trials for ophthalmology help researchers to evaluate novel medications, surgical techniques, and diagnostic tools, potentially leading to breakthroughs in managing or curing a range of conditions. Ophthalmology clinical trials play a key role in reducing the burden of visual impairment and blindness, enhancing eye health, and promoting better visual outcomes for future patients.

What types of clinical trials are used for ophthalmology?

Participation in an ophthalmology clinical trial

Who can participate in a clinical trial for ophthalmology?

How to enroll in a ophthalmology clinical trial